Upregulation of vitamin D receptor levels by 1,25(OH)(2) vitamin D-3 in cultured human keratinocytes

被引:26
作者
Solvsten, H
Svendsen, ML
Fogh, K
Kragballe, K
机构
[1] Department of Dermatology, Marselisborg Hospital
关键词
1,25-dihydroxyvitamin D-3; vitamin D receptor; keratinocytes; vitamin D receptor mRNA; 1,25-DIHYDROXYVITAMIN-D3 RECEPTORS; OSTEOSARCOMA CELLS; SARCOMA CELLS; EXPRESSION; DIFFERENTIATION; CLONING; BINDING; SYSTEM;
D O I
10.1007/s004030050206
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The natural biologically active form of vitamin D-3, 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), possesses antiproliferative, prodifferentiating and immunomodulatory properties. The actions of 1,25(OH),D, are mediated through the intracellular vitamin D receptor (VDR), and the level of VDR is believed to determine the cellular responsiveness to vitamin D-3. In the present study we examined the effects of 1,25(OH)(2)D-3 on the expression of VDR and its message in cultured human keratinocytes. Western analysis showed the mean VDR content to be higher in undifferentiated cultures (175 pg/mu g protein) than in differentiated cultures (90 pg/mu g protein). Incubation with 1,25(OH),D, induced an increase in the VDR in both undifferentiated and differentiated keratinocytes. The VDR increase was detectable after 2 h and maximal (approximately twofold stimulation) after 8 h. The 1,25(OH)(2)D-3-induced stimulation of VDR levels was dose dependent with a maximum at 10(-7) M. The VDR mRNA levels as determined by the ribonuclease protection assay showed a peak (50% stimulation) after approximately 2 h. Although this increase in VDR mRNA was not statistically significant, the results indicate that the ligand-induced upregulation of VDR involves increased transcription. The upregulation of VDR levels may increase the responsiveness to 1,25(OH)(2)D-3 and may, therefore, be an important mechanism for regulating the effects of 1,25(OH)(2)D-3 on keratinocyte proliferation and differentiation.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 24 条
[1]   CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR [J].
BAKER, AR ;
MCDONNELL, DP ;
HUGHES, M ;
CRISP, TM ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
PIKE, JW ;
SHINE, J ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3294-3298
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   HORMONAL RESPONSES TO 1,25-DIHYDROXYVITAMIN-D3 IN CULTURED MOUSE OSTEOBLAST-LIKE CELLS - MODULATION BY CHANGES IN RECEPTOR LEVEL [J].
CHEN, TL ;
LI, JM ;
VANYE, T ;
CONE, CM ;
FELDMAN, D .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 126 (01) :21-28
[4]  
CHEN TL, 1981, J BIOL CHEM, V256, P5561
[5]   REGULATION OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTORS BY VITAMIN-D ANALOGS IN CULTURED MAMMALIAN-CELLS [J].
COSTA, EM ;
HIRST, MA ;
FELDMAN, D .
ENDOCRINOLOGY, 1985, 117 (05) :2203-2210
[6]  
DOKOH S, 1984, CANCER RES, V44, P2103
[7]   DEMONSTRATION OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTORS IN HUMAN-SKIN BIOPSIES [J].
FELDMAN, D ;
CHEN, T ;
HIRST, M ;
COLSTON, K ;
KARASEK, M ;
CONE, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (06) :1463-1465
[8]  
HANAFIN NM, 1994, IN VITRO CELL DEV-AN, V30A, P187
[9]  
HENRIKSEN LO, 1996, IN PRESS SKIN PHARM
[10]   REGULATION OF 1,25(OH)2VITAMIN-D3 RECEPTOR CONTENT IN CULTURED LLC-PK1 KIDNEY-CELLS LIMITS HORMONAL RESPONSIVENESS [J].
HIRST, M ;
FELDMAN, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (01) :121-127